Elafros MABirbeck GLGardiner JCSiddiqi OKSikazwe IPaneth NBositis CMOkulicz JF2025-05-232017-Jun10.4269/ajtmh.16-0107https://pubs.cidrz.org/handle/123456789/10545AbstractConcurrent treatment with combination antiretroviral therapy (cART) and an enzyme-inducing antiepileptic drug (EI-AED) is common in resource-limited settings; however, the incidence and impact of adverse effects in cotreated patients is largely unknown. Symptoms of adverse effects were assessed by both spontaneous report and checklist for 145 human immunodeficiency virus (HIV)-infected Zambian adults initiating various treatment combinations, such as cART with an EI-AED (